|
End-of-day quote
Australian S.E.
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Nash
CEO | Chief Executive Officer | - | - |
Andrew Boyd
DFI | Director of Finance/CFO | - | 01/03/2011 |
| Corporate Officer/Principal | - | 01/03/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Nash
BRD | Director/Board Member | - | 01/03/2011 |
Brian McNamee
BRD | Director/Board Member | 70 | - |
Antoni M. Cipa
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.51% | +5.05% | +68.74% | +142.65% | 1,148B | |
| +1.57% | +2.61% | +47.15% | +86.75% | 652B | |
| +1.54% | +1.66% | +28.78% | +104.33% | 505B | |
| +1.02% | +2.50% | +54.34% | +66.56% | 384B | |
| +5.24% | +0.33% | +70.62% | +43.87% | 348B | |
| +2.79% | +2.90% | +34.64% | +56.71% | 294B | |
| +2.29% | +0.42% | +3.77% | +27.56% | 264B | |
| +2.21% | +3.12% | +58.08% | +75.25% | 244B | |
| +1.63% | +2.62% | +36.12% | +107.41% | 197B | |
| Average | +2.76% | +1.39% | +44.69% | +79.01% | 448.57B | |
| Weighted average by Cap. | +3.43% | +1.50% | +50.07% | +93.50% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ZTL Stock
Select your edition
All financial news and data tailored to specific country editions
